Aarti Industries Limited has informed the Exchange about Investor Presentation
AARTIIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Industries shared its AGM investor presentation covering FY25 performance and a 3-year growth roadmap. Revenue grew modestly to ₹8,046 Cr in FY25 with ~17% volume growth, but EBITDA remained muted at around the guided ₹1,000-1,050 Cr due to competitive pricing pressure and higher depreciation (₹434 Cr vs ₹378 Cr) and interest costs (₹275 Cr vs ₹211 Cr). Management outlined EBITDA drivers worth ₹1,450-2,150 Cr from cost optimisation (₹300-450 Cr), volume and margin ramp-up (₹350-500 Cr), capex-led growth (₹150-200 Cr), and speciality chemicals/JV ramp-up (₹650-1,000 Cr). Two new JVs were highlighted: Re Aarti (chemical recycling, 500 TPD by 2030) and Augene Chemical (specialty chemicals), both targeting CY26 commissioning. Capex is expected to decline after peaking in FY25, with FY26 capex estimated at ~₹1,000 Cr.
Management has laid out a clear path to nearly double EBITDA to ₹1,800-2,200 Cr over 3 years with improving returns (ROCE >15%, Debt/EBITDA <2.5x), but near-term margin headwinds from competition and energy segment pricing are acknowledged. FY26 capex moderation is a positive for cash flows, though execution of multiple growth projects and JV commissioning remain key risks to watch.